Saneca Pharmaceuticals has been acquired by AZC Group

Eterus Capital, a.s. has sold Saneca Pharmaceuticals, a.s. to AZC Group.

Saneca is a pharmaceutical contract manufacturing company active in the development, production, registration and distribution of generic medicines and active pharmaceutical ingredients. Saneca also owns a portfolio of cosmetics and generic products.

Based in Slovakia, AZC is an industrial business group operating in over 20 countries.

Founded in 2008, Eterus Capital is an investor targeting small and medium-sized companies with growth potential, that have successfully proved their business concept. The fund only invests in minority positions, while management control always remains in the hands of the original shareholders.

Oaklins’ team in Slovakia acted as the exclusive sell-side advisor in this transaction.